CI-922—A novel, potent antiallergic compound — II. Activity in animal models of allergy
- 1 January 1987
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 9 (1) , 51-60
- https://doi.org/10.1016/0192-0561(87)90110-x
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- CI-922 — A novel, potent antiallergic compound — I. Inhibition of mediator release in vitroInternational Journal of Immunopharmacology, 1987
- In vitro studies on the mechanism of action of a new antiallergic, Ro 21-7634Inflammation Research, 1981
- SRSA-mediated bronchospasm by pharmacologic modification of lung anaphylaxis in vivoInflammation Research, 1981
- New orally effective chromone derivatives for the treatment of asthmaInflammation Research, 1977
- The Mechanism of Tachyphylaxis to ICI 74,917 and Disodium CromoglycateInternational Archives of Allergy and Immunology, 1976
- Sodium Cromoglycate (Cromolyn Sodium)Drugs, 1974
- Effect of Disodium Cromoglycate on Various Types of Anaphylactic Reaction in the Guinea PigInternational Archives of Allergy and Immunology, 1973
- A heat labile mercaptoethanol susceptible homocytotropic antibody in the guinea pigLife Sciences, 1970
- Inhibition of Allergic Reactions in Man and Other Species by CromoglycateInternational Archives of Allergy and Immunology, 1970
- Versuchsanordnung zu Untersuchungen an der BronchiàlmuskulaturNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1940